DOCTOR SEARCH

Dr. LI Jun is Chief of General Surgery, Chief of Surgical Oncology at the Shanghai Jiahui International Hospital.

Dr. Li graduated at the Shanghai Medical University (now Fudan University), having the internship at Zhongshan Hospital and the Master degree at Cancer Hospital, Shanghai Medical University. He received the MD degree at the University of Essen in Germany and further the surgical training thereafter. He built his career in four prestigious European University Hospitals (Essen, London, Tübingen, Hamburg), with specialty of Surgery, General Surgery, Visceral Surgery, Hepato-Pancreatico-Biliary Surgery and Transplantation. Prior to Jiahui, he was in charge of Hepato-Pancreatico-Biliary Surgery at the University Medical Center Hamburg-Eppendorf, one of the five “Center of Excellence for Liver Surgery (DGAV)” in Germany.

Dr. Li has fundamental interesting in the surgical treatment of liver, biliary tract and pancreas disease. He made many surgical innovations. Some of them were published in the international prestigious journal. Applying the transplant technique and strategy on the treatment of cancers (as the part of transplant oncology) and performing minimal invasive surgery including robotic surgery (Da Vinci) are his current main focuses.

Dr. Li specializes in surgical techniques including but not limited to:
● Treatment of hepato-pancreatico-biliary malignancy, especially HCC, intrahepatic cholangiocarcinoma, perihilar cholangiocarcinom, gall bladder cancer, pancreas cancer and complex resection and reconstruction, including surgical palliation.
● Treatment of benign diseases of liver, biliary tract and pancreas, such as gall stone disease, iatrogenic biliary injury, intrahepatic stone disease, cystic liver lesion, portal hypertension. Many surgeries could be performed laparoscopically. Large part of liver benign tumor may not require a surgery. Some patients with jaundice can be treated non-surgically.
● Treatment of peritoneal and retroperitoneal tumor, which requiring reconstruction of large or small vessels, biliary tract, intestinal and even ureter.
● Treatment of gastro-intestinal tumor, including gastric cancer, colorectal cancer, tumor of the small bowel, gastrointestinal stromal tumor.
● Lymph nodes biopsy and lymphadnectomy in the area of neck, axillar, groin, abdomen or pelvis.
● Varies of laparoscopic operation, including liver resection, distal pancreas resection, gastrointestinal resection and reconstruction, cholecystectomy and hernia repair.

Dr. Li has wide international connection and reputation. He is the member of German Surgical Society, German Transplant Society, European Society of Transplantation, International Society of Transplantation, European Hepato-Pancreatico-Biliary Association, International European Hepato-Pancreatico-Biliary Association.

License no. :沪卫外医批字（2023）第046号

Chief Physician
Consultant of Urology at Jiahui Hospital

Clinical Experience:
Dr. Sean WANG is Vice Director, Urology Center, Shanghai General Hospital (China) and Director, Department of Urologic Oncology, Shanghai General Hospital (China). He also is Professor, Department of Urology, Huashan Hospital of Fudan University (China) and has been Visiting Doctor, Department of Urology and OB-GYN, Royal Victoria Hospital, McGill University (Canada), and in Cleveland Clinic at the department of Urology, and a Visiting Professor, Center for Male Reproductive Medicine & Micro Surgery Department of Urology, New York-Presbyterian Hospital, Cornell University (USA).

Dr. Sean Wang is an experienced senior specialist of Urology and Andrology with over 25 years working experience. He specializes in minimally invasive laparoscopic surgery for urinary system cancer（kidney cancer, bladder tumor, prostate cancer, adrenal tumor） and comprehensive treatment of andrology diseases (varicocele, hematospermia, prostatitis, male infertility, male sexual dysfunction, vasectomy, microsurgical vas reversal, etc.).

Dr. LIU Dongming is the Chief Physician of Urology at Renji Hospital, affiliated with the Shanghai Jiao Tong University School of Medicine, a Professor, and a Master's Supervisor. He studied under Professor Jiang Yu, a leading figure in Chinese urology, and from 1992 to February 1994, he trained under the internationally renowned urologist Professor F. Pagano at the Urological Research Institute of the University of Padova in Italy. Dr. LIU is the pioneer of laparoscopic surgery in the urology department at Renji Hospital, and his medical team has since accumulated over 20,000 cases of various laparoscopic surgeries. He also serves as a Visiting Professor at the Urological Research Institute of the University of Padova, a Visiting Scholar at the University of California, San Francisco (UCSF), the Deputy Head of the Shanghai Minimally Invasive Urology Group, and a Senior Expert at the Shanghai Urological Disease Consultation Center.

With over 30 years of clinical experience in urology, Dr. LIU is highly skilled in the diagnosis and treatment of urological diseases, specializing in minimally invasive urological surgeries, particularly for urological tumors. This includes laparoscopic surgeries for complex renal tumors, adrenal diseases, prostate and bladder tumors, as well as surgical treatments for complex renal cell carcinoma, bilateral renal tumors, solitary renal tumors, tumors with vena cava tumor thrombi, and large adrenal tumors. Dr. Liu was the first to propose the concept of targeted renal tumor vessels and pioneered the 3D imaging technique for zero-ischemia laparoscopic kidney-sparing surgery for renal tumors. To date, he has performed over 500 such surgeries.

Dr. LYU Chen serves as section head of Urology Department at Jiahui Health. With more than 20 years of clinical experience in Urology, Dr. LYU specializes in performing ultra-minimally invasive surgeries for benign prostatic hyperplasia (BPH), endoscopic procedures for urinary stones, laparoscopic/robotic surgeries for urological tumors, and comprehensive treatment of prostate cancer. He provides diagnostic and therapeutic services for common urological disorders while also possessing extensive clinical expertise in men's health management.

Dr. LYU graduated from XiangYa School of Medicine, Central South University, and completed advanced training in urologic oncology at Western University in Canada. . In 2015, he completed further training at the Chinese University of Hong Kong and was certified to operate the da Vinci robotic surgical system. Prior to joining Jiahui Health, Dr. Lyu served as a Urologist in the Urology department of Changhai Hospital, specializing in the diagnosis and comprehensive treatment of urologic tumors. During his career at Changhai Hospital, he participated in over 700 robotic-assisted urologic surgeries, and engaged in several international multi-center GCP projects on advanced urologic tumors.

Dr. LYU is a member of the Urology Subcommittee of the Shanghai Medical Doctor Association. In 2014, Dr. LYU was selected as a member of the "Rising Stars of Medical Talent" Youth Development Program jointly funded by the Shanghai Municipal Health Commission and Shanghai Medical and Healthcare Development Foundation. In 2016, he led and completed a research project funded by the National Natural Science Foundation of China. In addition, Dr. Lyu is the member of American Urological Association(AUA), European Association of Urology(EAU) and International Society for Sexual Medicine (ISSM). He has published 16 papers in SCI journals, and has been invited as guest speaker in several international academic conferences on Urology.

Dr. LYU’s treatment specialties include but are not limited to:
Benign Prostatic Hyperplasia (BPH): ultra-minimally invasive surgeries（Rezūm Water Vapor Therapy, UroLift Procedure etc.））, Blue Laser Vaporization，Transurethral Resection of the Prostate (TURP).
Urinary System Calculi (Stone): management of renal/ureteral stones via rigid ureteroscopic lithotripsy and single-session flexible ureteroscopy etc.
Urologic Oncology: mMinimally invasive laparoscopic/robotic surgeries & multimodal management for renal tumors, prostate cancer, bladder carcinoma and adrenal neoplasms etc.
Voiding Dysfunction: uUrodynamic evaluation & comprehensive therapy for stress urinary incontinence, neurogenic bladder and overactive bladder syndrome.
Andrological Disorders: : dDiagnostic assessment, behavioral intervention & integrated management of Varicocele, male hypogonadism, Erectile dysfunction and Prostatitis.

Professor SUN Jian (MD，PhD) has been engaged in clinical, teaching and scientific research in the field of oral and maxillofacial-head and neck tumors. In particular, it enjoys a reputation in radical surgery, postoperative defect repair and functional reconstruction. It has taken the lead in successfully carrying out a number of difficult, functional and pioneering surgeries in China.

He has won the First Prize of Science and Technology Progress of the Ministry of Education (the first winner), the Second Prize of National Science and Technology Progress (the second winner in 2019, the fourth winner in 2007). He edited and published monograph on head and neck functional surgery in China, Maxillofacial Functional Surgery. He also has undertaken a number of National Natural Science Foundation projects and provincial and ministerial projects, and has published more than 160 papers, including more than 60 SCI papers.

Expertise
Calculus of intrahepatic and extrahepatic duct, cholecystolithiasis, biliary tract neoplasms, acute and chronic pancreatitis, benign and malignant thyroid tumors, skin and subcutaneous tumors

Personal Profile
Dr. FEI Jian is a multi-practitioner of Shanghai Jiahui International Hospital. He is the Master's supervisor of Shanghai Jiao Tong University School of Medicine, Chief physician of General Surgery Department of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, and Vice President of Luwan Branch of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine.

Dr. FEI graduated from Shanghai Second Medical University with a master's degree in 1996, with the guidance of renowned Chinese surgical expert Professor Zhang Shengdao and Professor Jiang Yu. In 2001, he obtained his doctoral degree from Shanghai Second Medical University (now Shanghai Jiao Tong University School of Medicine). In 2005-2006, he engage in advanced studies at the European Pancreatic Center - ULM University Surgical Hospital in Germany.

Dr. FEI mainly focuses on the basic and clinical research of thyroid cancer, severe acute pancreatitis, pancreatic cancer and gallstone disease. In recent years, he has undertaken the National Natural Science Foundation project, the key project of Shanghai Science and Technology Commission, the Shanghai Municipal Health Commission, and the key project of Shanghai Jiao Tong University. He has published more than 70 relevant papers (including more than 30 SCI and EI publications), won more than 10 national patents, and successively won the China Medical Science and Technology Award, Huaxia Medical Science and Technology Award, Shanghai Science and Technology Progress Award, and Shanghai Medical Science and Technology Award.

Dr. FEI specializes in treating various diseases including but not limited to:
1 Thyroid diseases: benign and malignant thyroid tumors, etc.
2 Biliary tract: calculus of intrahepatic and extrahepatic duct, cholecystolithiasis, biliary tract tumors, etc.
3 Complex pancreatic diseases: acute and chronic pancreatitis, pancreatic tumors, etc.
4 Skin and subcutaneous tumors

Social employment
Member of the Editorial Committee for the Humanities and Medicine Section of the Public Course on Standardized Training for Resident Physicians of the Chinese Medical Doctor Association
Member of standing Committee of the Robotics Group of the Thyroid Professional Committee of the Chinese Medical Doctor Association
Member of the Biological Sample Bank Branch of the China Medical Biotechnology Association
Formerly served as a contributing editor for Journal of Chinese Clinical Medicine
Formerly served as a peer reviewer for Journal of Clinical Hepatology

Dr. Louis PAN is the Section Head of Endocrine Surgery, as attending surgeon in Department of General Surgery of Jiahui Health.

He obtained his PhD degree in General Surgery from the Chinese University of Hong Kong, with a research interest in minimally invasive surgical technology. He has published more than ten academic research articles on major professional journals, including Chinese local and international peer review journals (SCI). Based on his research, Dr. Pan published papers and gave presentations at a number of international academic conferences (including 2015 World Congress of Surgery (WCS) and 2016 Digestive Disease Week® (DDW)). Dr. Louis PAN obtained his master's degree in Surgery from Shanghai Jiao Tong University School of Medicine in 2005, during which he completed the internship and surgical training program in Hôpital Civil in Strasbourg, France.

With more than twenty years of clinical practice in surgical department, he has extensive experience in treating common diseases in general surgery, such as surgical operations on thyroid/parathyroid gland diseases, laparoscopic operations on biliary system and abdominal wall hernia's, etc. He has also played important role in metabolic and bariatric treatment program, as a surgeon for bariatric surgery.
He holds the certificate of Da Vinci robotic surgical system.

Dr. Louis PAN specializes in treating various diseases, including but not limited to:
• Thyroid/parathyroid conditions (benign and malignant), including using endoscopic approach without scar left in neck.
• Abdominal wall hernia, especially using minimally invasive surgical approach, laparoscopic hernia repair.
• Digestive diseases which need surgical interventions including emergent procedures, like biliary calculosis, benign gastrointestinal tumors and inflammatory disorders (appendicitis, diverticulitis, etc.)
• Bariatric surgery.
• Perianal diseases, like hemorrhoids, anal fistula and anal fissure.

Dr. Li Qinyu is the associate Professor, Doctor of Medicine, Deputy Chief Physician of General Surgery, Ruijin Hospital Shanghai Jiaotong University School of Medicine, part-time doctor of General surgery of Jiahui Health.

From 2003 to 2004, he visited the Queen Mary Hospital of the University of Hong Kong. In 2016 and 2017, he visited Yonsei University in South Korea and Johns Hopkins University in the United States for exchange studies.

He has been engaged in the diagnosis and surgical treatment of thyroid diseases, focusing on the specialized application of minimally invasive technology (endoscopy, robotic system, ablation technology). Specializes in all kinds of benign and malignant thyroid and parathyroid disease precision surgery, including giant thyroid tumor, hyperthyroidism, retrosternal thyroid tumor surgery, recurrent thyroid surgery and neck lymph node dissection. He specializes in the application of minimally invasive neck surgery techniques, including minimally invasive thyroid and parathyroid surgeries such as axillary approach, breast approach, transoral approach, and Miccoli surgery with small incision in neck. He is good at functional protection (nerve, parathyroid exposure protection and functional neck lymph node dissection). He has published more than 20 papers in scientific journals, including 6 SCI papers, and participated in the preparation of 2 monographs. He has led and participated in a number of national and Shanghai Science and Technology Commission and Health Bureau projects.

Areas of expertise:
Thyroid surgery, gastrointestinal tumor surgery and robotic, endoscopic minimally invasive surgery techniques
(Thyroid, parathyroid benign and malignant tumors surgery and endoscopic minimally invasive technology, radiofrequency ablation technology application)

Chief Surgeon, Professor, General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Dr Qiu obtained his medical license from Shanghai Bureau of Health in the year of 2000, and he was certified by ECFMG/USMLE, USA in 2003. Dr Qiu is good at digestive tract tumors, comprehensive treatment of difficult and complex thyroid tumors, scarless minimally invasive laparoscopic thyroid surgery, thyroid diseases treatment.

 
Dr. Qiu has completed more than 9,000 thyroid surgeries, nearly 1,000 single-port endoscopic thyroid surgeries, hundreds of hepatobiliary and minimally invasive hepatobiliary and pancreatic surgeries, hundreds of gastrointestinal tumor surgeries, and participated in more than 80 liver transplant surgeries. Undertook 5 National Natural Science Foundation of China and published more than 60 SCI papers as the first author and corresponding author.

PROFESSIONAL SOCIETIES:

●Certified by ECFMG/USLME, USA

●Member of National Board of Chinese Society of Surgery

●Member of Chinese Society of Clinical Oncology

●Member of China Anti-Cancer Association

●Minimally Invasive and Noninvasive Medicine Committee of CMDA

●American Association for Cancer Research

●European Association for Cancer Research

●Academy of Surgical Research, USA

 Dr. JI Qinghai is currently the specially-invited consultant of General Surgery Department of Jiahui Health. Dr. Ji graduated from Shanghai Medical University in 1983 and received his master's degree in Clinical Medicine from Shanghai Medical University in 1993. He was the Chief of Head & Neck Surgery Department at Fudan University Shanghai Cancer Center, the chief expert and the convenor of the multidisciplinary comprehensive treatment group of Head & Neck Cancer at Fudan University Shanghai Cancer Center. Dr. Ji Qinghai is the vice Chairman of the Thyroid Cancer Committee of the Chinese Anti-Cancer Association, the vice chairman of the thyroid Cancer Committee of the Chinese Medical Doctor Association, the chairman of the Thyroid Cancer Committee of the Shanghai Anti-Cancer Association, and the leader of the Thyroid Science Group of the General Surgery Committee of the Shanghai Medical Association. Member of Standing Committee of Head & Neck Tumor Professional Committee of China Anti-Cancer Association and former chairman of Head & Neck Tumor Professional Committee of Shanghai Anti-Cancer Association.

He is the editoiral board member of Chinese Journal of Otolaryngology -- Head & Neck Surgery, Chinese Journal of Surgery, Chinese Journal of Cancer, Journal of Chinese Academy of Medical Sciences, Cancer, Chinese Journal of Cancer, Chinese Medical Journal, Medicine, World Journal of Surgical Oncology, Oncotargets and Therapy.

Dr. Ji has been engaged in head & neck cancer surgery for more than 30 years, focusing on clinical and basic research in the treatment of thyroid, laryngeal, hypopharyngeal and tongue cancers. "Surgical treatment of thyroid cancer invading piriform fossa" won the Clinical Achievement Award of Fudan University. Professor Ji Qinghai has presided over a number of major projects of Shanghai Science and Technology Commission, major basic research projects of Shanghai and top priority projects of Shanghai. He has led the research direction of papillary thyroid cancer in China and committed himself to the formulation of diagnosis and treatment standards for papillary thyroid cancer and the standardized training of thyroid surgeons. Since 2015, he has gone throughout the country to promote the standardization of diagnosis and treatment of thyroid cancer, and the specialization of thyroid surgeon training in China.

Areas of expertise:
Diagnosis and surgical treatment of head & neck tumors, including thyroid, salivary glands, oral tumors and laryngeal and laryngeal cancers.